Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03010969
Other study ID # POETRY abdominal
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 2016
Est. completion date November 2019

Study information

Verified date February 2021
Source Zealand University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of the clinical study is: 1. to examine the association between postoperative endothelial function, indirectly measured by reactive hyperemia index, and major adverse cardiovascular events including myocardial injury and cardiac death within 30, 90 and 365 days of acute abdominal surgery. 2. to examine the association between postoperative endothelial function, indirectly measured by reactive hyperemia index, and non-cardiovascular complications including non-cardiac death within 30, 90 and 365 days of acute abdominal surgery. 3. to examine the importance of the postoperative blood glucose level and the pulmonary function for postoperative complications and death within 30, 90 and 365 days of acute abdominal surgery. 4. to examine the association between postoperative endothelial function, pulmonary function and blood glucose level 5. the qualitative part of the study will examine the postoperative subjective symptoms including acute and chronic pain, quality of recovery and functional status, depressive thoughts and post-traumatic stress disorder.


Recruitment information / eligibility

Status Completed
Enrollment 224
Est. completion date November 2019
Est. primary completion date November 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria - = 18 years old - Surgery within 72 hours of an acute admission to the Department of Surgery or an acute reoperation. - Major gastrointestinal surgery on the gastrointestinal tract. This will include - Open, laparoscopic, or laparoscopically-assisted procedures - Procedures involving the stomach, small or large bowel, or rectum for conditions such as perforation, ischaemia, abdominal abscess, bleeding or obstruction - Washout/evacuation of intra-peritoneal abscess (unless due to appendicitis or cholecystitis - excluded, see below) - Washout/evacuation of intra-peritoneal hematoma - Bowel resection/repair due to incarcerated umbilical, inguinal and femoral hernias (but not hernia repair without bowel resection/repair) - Bowel resection/repair due to obstructing/incarcerated incisional hernias provided the presentation and findings were acute - Laparotomy/laparoscopy with inoperable pathology (e.g. peritoneal/hepatic metastases) - Laparoscopic/Open Adhesiolysis - Return to theatre for repair of fascial dehiscence - Any reoperation/return to theatre meeting the criteria above is included If multiple procedures (primary surgery or reoperation) are performed on different anatomical sites within the abdominal/pelvic cavity, the patient would be included if the major procedure is general surgical. Exclusion criteria - Not capable of giving informed consent after oral and written information - Previously included in the trial - If transferred directly from the operation room or recovery ward to the intensive care unit - Elective laparoscopy - Diagnostic laparotomy/laparoscopy where no subsequent procedure is performed (NB, if no procedure is performed because of inoperable pathology, then include) - Appendectomy +/- drainage of localized collection unless the procedure is incidental to a non-elective procedure on the GI tract - Cholecystectomy +/- drainage of localized collection unless the procedure is incidental to a non-elective procedure on the GI tract (All surgery involving the appendix or gallbladder, including any surgery relating to complications such as abscess or bile leak is excluded) - Non-elective hernia repair without bowel resection. - Minor abdominal wound dehiscence unless this causes bowel complications requiring resection - Ruptured ectopic pregnancy, or pelvic abscesses due to pelvic inflammatory disease - Laparotomy/laparoscopy for pathology caused by blunt or penetrating trauma - Laparotomy/laparoscopy for esophageal pathology Laparotomy/laparoscopy for pathology of the spleen, renal tract, kidneys, liver, gall bladder and biliary tree, pancreas or urinary tract

Study Design


Intervention

Procedure:
Acute abdominal surgery
Acute abdominal surgery within 72 hours of admission to the department of surgery

Locations

Country Name City State
Denmark Department of Surgery, Zealand University Hospital, Koge Køge

Sponsors (1)

Lead Sponsor Collaborator
Zealand University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Postoperative quality of recovery (QoR15) QoR15 score postoperative day 1, 3, 5, 7, 14, 30, 90 and 365
Other Numerical rating scale (NRS) pain score NRS pain score in rest and at activity postoperative day 1, 3, 5, 7, 14, 30, 90 and 365
Other Post-Traumatic Stress Disorder Post-Traumatic Stress Disorder questionnaire postoperative day 14, 30, 90 and 365
Other Depressive thoughts Hospital anxiety and depression scale postoperative day 14, 30, 90 and 365
Other Postoperative pain Questionnaire Self-reported Leeds Assessment of Neuropatic Symptoms and Signs pain scale (S-LANSS) postoperative day 14, 30, 90 and 365
Other Functional status Activity Assessment Scale postoperative day 14, 30, 90 and 365
Primary The change in reactive hyperemia index assessed by EndoPat The change from 4-24 hours to between day 3 and 5 after surgery
Primary Major adverse cardiovascular events Cardiovascular death
Myocardial injury within postoperative day 3 (definition: peak plasma cardiac troponin-I = 45ng/L (99th percentile URL, 10% CV at 40ng/L))
Acute coronary syndrome (unstable angina pectoris, NSTEMI, STEMI)
Congestive heart failure
Stroke
Nonfatal cardiac arrest
New clinically important cardiac arrhythmia
Coronary revascularization procedure (PCI or CABG)
Sudden unexpected death
Within 365 days of surgery
Primary Postoperative non-cardiovascular complications Non-cardiovascular death, sepsis, pneumonia, respiratory failure, surgical complications (min. Clavien-Dindo stage 3), Any non-cardiovascular life-threatening complication (Clavien-Dindo stage 4). Within 365 days of surgery
Secondary Nitric oxide biomarkers 4-24 hours after surgery and between postoperative day 3-5
Secondary Reactive hyperemia index assessed by EndoPat 4-24 hours after surgery
Secondary Reactive hyperemia index assessed by EndoPat between day 3 and 5 after surgery
Secondary Blood Glucose level Postoperative day 1 - 7 (or until discharge)
Secondary Pulmonary function Postoperative day 1 - 7 (or until discharge)
Secondary Readmission Readmissions within 1 year of discharge
Secondary Lengths of stay Lengths of stay from the operation day to discharge, on average 14 days.
Secondary Lengths of stay in the intensive care unit Lengths of stay from the operation day to discharge from hospital, on average 14 days.
See also
  Status Clinical Trial Phase
Recruiting NCT05243446 - Cardiorenal Effecs of Losartan in Kidney Transplant Recipients
Completed NCT06089226 - Parameters Related to Physical Activity Level in SCI
Recruiting NCT04696081 - Atrial Fibrillation in Active Cancer Patients
Completed NCT05687097 - Untreated Sleep Apnea as an Aggravating Factor for Other Secondary Medical Conditions After Spinal Cord Injury
Completed NCT03274869 - Scrub Typhus Infection Induced Cardiovascular Disease
Completed NCT04025086 - Perioperative Goal Directed Therapy (PGDT) in Spinal Surgery in the Prone Position
Completed NCT01413815 - Effect of the Amino Acid L-arginine on Perioperative Cardio-vascular Risk in Non-selected Patients N/A
Recruiting NCT05077748 - An 18-year Follow-up Study on OSA in a Population-based Cohort
Not yet recruiting NCT06279000 - Colchicine in Patients at Cardiac Risk Undergoing Major Non-Cardiac Surgery Phase 3
Enrolling by invitation NCT06360666 - Clinical Outcomes in Adult Patients Undergoing Laparoscopic Surgery Under Neuraxial Anesthesia
Recruiting NCT03977337 - Perioperative Pulmonary Monitoring in Major Emergency Surgery
Recruiting NCT05996965 - Evaluation of Clinical Utility of Non-invasive Hemodynamic Monitoring Device
Recruiting NCT05349955 - Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community N/A
Withdrawn NCT04435015 - The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications Phase 1/Phase 2
Active, not recruiting NCT05745090 - N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) in Type 2 Diabetes Mellitus
Terminated NCT03760159 - Minimally Invasive Detection of a Sleep Apnoea
Completed NCT04802122 - Induction of Anesthesia With Sevoflurane Preserving Spontaneous Breathing: Cardiorespiratory Effects. Phase 4
Not yet recruiting NCT06419270 - Cardiovascular, Renal, and Skeletal Complications in Patients With Post-Surgical Hypoparathyroidism
Recruiting NCT05895669 - Cardiovascular Outcomes in Orthotopic Liver Transplanted Patients (COLT Study)
Completed NCT05685979 - Evaluation of Cardiac Functions in Deep Trendelenburg Position